Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/statins-and-aspirin-do-they-really-work-in-women-va3sgrElvx
References (97)
-
P. Sutcliffe, M. Connock, T. Gurung, K. Freeman, S. Johnson, K. Ngianga-Bakwin, A. Grove, B. Gurung, S. Morrow, S. Stranges, A. Clarke (2013)
Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized TrialsPLoS ONE, 8
-
K. Egashira, Y. Hirooka, H. Kai, M. Sugimachi, Satoshi Suzuki, T. Inou, A. Takeshita (1994)
Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.Circulation, 89 6
-
P. Ridker, N. Cook (2013)
Statins: new American guidelines for prevention of cardiovascular diseaseThe Lancet, 382
-
C. Schooling, Shiu Lun, Au Yeung, G. Freeman, B. Cowling (2013)
The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trialsBMC Medicine, 11
-
S. Kjeldsen, R. Kolloch, G. Leonetti, J. Mallion, A. Zanchetti, D. Elmfeldt, I. Warnold, L. Hansson (2000)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.Journal of hypertension, 18 5
-
N. Cook, N. Paynter, C. Eaton, J. Manson, L. Martin, Jennifer Robinson, J. Rossouw, S. Wassertheil-Smoller, P. Ridker (2012)
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health InitiativeCirculation, 125
-
J. Belch, A. Maccuish, Iain Campbell, S. Cobbe, Roy Taylor, R. Prescott, Robert Lee, Jean Bancroft, Shirley MacEwan, J. Shepherd, P. Macfarlane, A. Morris, R. Jung, C. Kelly, A. Connacher, N. Peden, A. Jamieson, D. Matthews, G. Leese, J. McKnight, I. O'Brien, C. Semple, J. Petrie, D. Gordon, S. Pringle, R. Macwalter (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseThe BMJ, 337
-
Sadanori Okada, T. Morimoto, H. Ogawa, M. Kanauchi, M. Nakayama, S. Uemura, N. Doi, H. Jinnouchi, M. Waki, H. Soejima, M. Sakuma, Yoshihiko Saito (2011)
Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes ManagementDiabetes Care, 34
-
A. Olsson, J. Mcmurray, G. Thorgeirsson, C. Spaulding, J. Slattery, K. Pyörälä, O. Faergeman, R. Wright, Kåre Berg, L. Wilhelmsen, T. Pedersen, T. Miettinen, H. White, J. Kjekshus, M. Gnant (1994)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.Atherosclerosis. Supplements, 5 3
-
PM Ridker, NR Cook, IM Lee, D Gordon, JM Gaziano, JE Manson (2005)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in womenN Engl J Med, 352
-
EH Awtry, J Loscalzo (2000)
AspirinCirculation, 101
-
I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cífková, J. Dallongeville, Guy Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, Stephen Humphries, M. Knapton, J. Perk, S. Priori, K. Pyôrâlà, Ž. Reiner, L. Ruilope, Susana Sans-Menendez, Wilma Reimer, P. Weissberg, D. Wood, J. Yarnell, J. Zamorano, Edmond Walma, Tony Fitzgerald, M. Cooney, A. Dudina (2007)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invitEuropean heart journal, 28 19
-
M. Roizen (2010)
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized TrialsYearbook of Anesthesiology and Pain Management, 2010
-
L. Mosca, E. Benjamin, K. Berra, J. Bezanson, R. Dolor, D. Lloyd‐Jones, L. Newby, I. Piña, V. Roger, L. Shaw, Dong Zhao, Theresa Beckie, C. Bushnell, J. D’Armiento, P. Kris-Etherton, Jing Fang, T. Ganiats, A. Gomes, C. Gracia, C. Haan, E. Jackson, D. Judelson, E. Kelepouris, C. Lavie, A. Moore, N. Nussmeier, E. Ofili, S. Oparil, P. Ouyang, V. Pinn, K. Sherif, Sidney Smith, G. Sopko, N. Chandra‐Strobos, E. Urbina, V. Vaccarino, N. Wenger (2011)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.Journal of the American College of Cardiology, 57 12
-
(2001)
Treatment of high blood cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA, 285
-
T. Ivanova (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice -
JJ Kastelein, F Akdim, ES Stroes, AH Zwinderman, ML Bots, AF Stalenhoef (2008)
Simvastatin with or without ezetimibe in familial hypercholesterolemiaN Engl J Med., 358
-
S Okada, T Morimoto, H Ogawa, M Kanauchi, M Nakayama, S Uemura (2011)
Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trialDiabetes Care, 34
-
Kendall, Toescu (1998)
The HOT StudyJournal of Clinical Pharmacy and Therapeutics, 23
-
A. Tonkin, D. Colquhoun, J. Emberson, W. Hague, A. Keech, G. Lane, S. MacMahon, R. Simes, P. Thompson, H. White, D. Hunt, J. Shaw (2000)
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID studyThe Lancet, 356
-
L. Hansson, A. Zanchetti, S. Carruthers, B. Dahlöf, D. Elmfeldt, S. Julius, J. Ménard, K. Rahn, H. Wedel, S. Westerling (1998)
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 351
-
L. Zaputović (2006)
Hypertension optimal treatment, 1
-
K. Mizuno, N. Nakaya, Y. Ohashi, N. Tajima, T. Kushiro, T. Teramoto, S. Uchiyama, H. Nakamura (2008)
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)Circulation, 117
-
J. Hopkins, M. Limacher (2009)
The Role of Aspirin in Cardiovascular Disease Prevention in WomenAmerican Journal of Lifestyle Medicine, 3
-
M. Roncaglioni (2001)
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general PracticeThe Lancet, 357
-
S Mora, RJ Glynn, J Hsia, JG MacFadyen, J Genest, PM Ridker (2010)
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trialsCirculation, 121
-
E. Bruckert, G. Hayem, S. Dejager, C. Yau, B. Bégaud (2005)
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO StudyCardiovascular Drugs and Therapy, 19
-
(1989)
Final report on the aspirin component of the ongoing Physicians' Health Study.The New England journal of medicine, 321 3
-
S. Kjeldsen, R. Kolloch, G. Leonetti, Jean-Michel Malliond, A. Zanchetti, D. Elmfeldt, I. Warnold, L. Hansson (2000)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT studyJournal of Hypertension, 18
-
W. Jetter (1948)
The Salicylates, A Critical Bibliographic Review -
C. Baigent, C. Sudlow, R. Collins, R. Peto, Antithromboci Collaborat (2002)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ : British Medical Journal, 324
-
J. Zalewska (2009)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled TrialYearbook of Vascular Surgery, 2009
-
E. Huang, L. Strate, Wendy Ho, Salina Lee, A. Chan (2011)
Long-term use of aspirin and the risk of gastrointestinal bleeding.The American journal of medicine, 124 5
-
W. Kostis, Jerry Cheng, J. Dobrzynski, J. Cabrera, J. Kostis (2012)
Meta-analysis of statin effects in women versus men.Journal of the American College of Cardiology, 59 6
-
M. Schartl, W. Bocksch, D. Koschyk, W. Voelker, K. Karsch, J. Kreuzer, D. Hausmann, S. Beckmann, M. Gross (2001)
Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery DiseaseCirculation: Journal of the American Heart Association, 104
-
R. Peto, R. Gray, R. Collins, K. Wheatley, C. Hennekens, K. Jamrozik, C. Warlow, B. Hafner, E. Thompson, S. Norton, J. Gilliland, R. Doll (1988)
Randomised trial of prophylactic daily aspirin in British male doctorsBritish Medical Journal (Clinical research ed.), 296
-
F. Fowkes, J. Price, Marlene Stewart, I. Butcher, G. Leng, Alistair Pell, P. Sandercock, K. Fox, G. Lowe, G. Murray (2010)
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.JAMA, 303 9
-
A. Bartolucci, M. Tendera, G. Howard (2011)
Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.The American journal of cardiology, 107 12
-
C. Treasure, J. Klein, W. Weintraub, J. Talley, M. Stillabower, A. Kosinski, Jian Zhang, S. Boccuzzi, J. Cedarholm, R. Alexander (1995)
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.The New England journal of medicine, 332 8
-
PM Ridker, JG MacFadyen, FAH Fonseca, J Genest, AM Gotto, JJP Kastelein (2009)
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)Circ Cardiovasc Qual Outcomes, 2
-
M. Sacco, F. Pellegrini, M. Roncaglioni, F. Avanzini, G. Tognoni, A. Nicolucci (2003)
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.Diabetes care, 26 12
-
C. Hennekens, C. Hennekens, F. Sacks, F. Sacks, A. Tonkin, A. Tonkin, J. Jukema, R. Byington, R. Byington, B. Pitt, B. Pitt, D. Berry, S. Berry, N. Ford, Andrew Walker, Kannan Natarajan, Sheng-Lin Chen, F. Fiedorek, René Belder (2003)
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.Archives of internal medicine, 164 1
-
D. Mccarey, I. McInnes, R. Madhok, R. Hampson, O. Scherbakova, I. Ford, H. Capell, N. Sattar (2004)
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialThe Lancet, 363
-
Q. Truong, S. Murphy, C. Mccabe, A. Armani, C. Cannon (2011)
Benefit of Intensive Statin Therapy in Women: Results From PROVE IT-TIMI 22Circulation: Cardiovascular Quality and Outcomes, 4
-
J. Liao, U. Laufs (2005)
Pleiotropic effects of statins.Annual review of pharmacology and toxicology, 45
-
H. Colhoun, D. Betteridge, P. Durrington, G. Hitman, H. Neil, S. Livingstone, M. Thomason, M. Mackness, V. Charlton-menys, J. Fuller (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 364
-
S. Seshasai, Shanelle Wijesuriya, Rupa Sivakumaran, S. Nethercott, S. Erqou, N. Sattar, K. Ray (2012)
Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.Archives of internal medicine, 172 3
-
P. Vandvik, A. Lincoff, Joel Gore, D. Gutterman, Frank Sonnenberg, P. Alonso-Coello, E. Akl, M. Lansberg, Gordon Guyatt, Frederick Spencer (2012)
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 141 2 Suppl
-
A. Go, D. Mozaffarian, V. Roger, E. Benjamin, J. Berry, W. Borden, D. Bravata, S. Dai, E. Ford, C. Fox, Sheila Franco, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, Mark Huffman, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Magid, G. Marcus, A. Marelli, D. Matchar, Darren Mcguire, E. Mohler, C. Moy, M. Mussolino, G. Nichol, N. Paynter, P. Schreiner, P. Sorlie, J. Stein, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2013)
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.Circulation, 127 1
-
J. Perk, G. Backer, H. Gohlke, I. Graham, Željko Reiner, W. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková, C. Deaton, S. Ebrahim, Miles Fisher, G. Germano, R. Hobbs, A. Hoes, Ş. Karadeniz, A. Mezzani, E. Prescott, L. Rydén, M. Scherer, M. Syvänne, W. Reimer, C. Vrints, D. Wood, J. Zamorano, F. Zannad, Developed Rehabilitation (2012)
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)International Journal of Behavioral Medicine, 19
-
PM Ridker, E Danielson, FA Fonseca, J Genest, AM Gotto, JJ Kastelein (2008)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med., 359
-
R. Rosenson, C. Tangney (1998)
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.JAMA, 279 20
-
G. Moneta (2009)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinYearbook of Vascular Surgery, 2009
-
Akira Endo (1992)
The discovery and development of HMG-CoA reductase inhibitors.Journal of lipid research, 33 11
-
N. Calonge, D. Petitti, T. Dewitt, L. Gordis, K. Gregory, Russell Harris, G. Isham, M. LeFevre, C. Loveland-Cherry, L. Marion, V. Moyer, J. Ockene, G. Sawaya, A. Siu, S. Teutsch, B. Yawn (2009)
Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.Annals of Internal Medicine, 150
-
S. Lewis, F. Sacks, J. Mitchell, C. East, S. Glasser, Sheren Kell, R. Letterer, M. Limacher, L. Moye, J. Rouleau, M. Pfeffer, E. Braunwald (1998)
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.Journal of the American College of Cardiology, 32 1
-
Matt Fisher, M. Cushman, V. Knappertz, G. Howard (2008)
An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration.American heart journal, 156 1
-
V. Fonseca, N. Clark (2006)
Standards of Medical Care in Diabetes: Response to PowerDiabetes Care, 29
-
J. Shepherd, G. Blauw, M. Murphy, E. Bollen, B. Buckley, S. Cobbe, I. Ford, A. Gaw, M. Hyland, J. Jukema, A. Kamper, P. Macfarlane, A. Meinders, J. Norrie, C. Packard, I. Perry, D. Stott, Brian Sweeney, Gillian Twomey, R. Westendorp (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialThe Lancet, 360
-
S. Lakoski, P. Greenland, N. Wong, P. Schreiner, D. Herrington, R. Kronmal, Kiang Liu, R. Blumenthal (2007)
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA).Archives of internal medicine, 167 22
-
Kunal Karmali, D. Goff, Hongyan Ning, D. Lloyd‐Jones (2014)
A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.Journal of the American College of Cardiology, 64 10
-
V. Le, S. Knight, B. Horne, H. May, Jeffrey Anderson, J. Muhlestein (2014)
HOW WELL DOES THE FRAMINGHAM RISK SCORE PREDICT CARDIAC OUTCOMES IN WOMEN AS ASSESSED BY CORONARY ANGIOGRAPHY? THE INTERMOUNTAIN HEART COLLABORATIVE STUDYJournal of the American College of Cardiology, 63
-
F. Guo, D. He, Wei Zhang, R. Walton (2012)
Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010.Journal of the American College of Cardiology, 60 7
-
M. Lièvre, M. Cucherat (2009)
Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta‐analysisFundamental & Clinical Pharmacology, 24
-
C. Baigent, L. Blackwell, R. Collins, J. Emberson, Jon Godwin, R. Peto, Julie Buring, Charles Hennekens, Patricia Kearney, Tom Meade, Carlo Patrono, M. Roncaglioni, Alberto Zanchetti (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet, 373
-
A. Culver, I. Ockene, R. Balasubramanian, B. Olendzki, Deidre Sepavich, J. Wactawski‐Wende, J. Manson, Y. Qiao, Y. Qiao, Simin Liu, P. Merriam, Catherine Rahilly-Tierny, Fridtjof Thomas, J. Berger, J. Ockene, J. Curb, Yunsheng Ma (2012)
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.Archives of internal medicine, 172 2
-
Luni Chen (2008)
Simvastatin With or Without Ezetimibe in Familial HypercholesterolemiaJournal of Evidence-based Medicine
-
G. Gibbons, J. Harold, M. Jessup, R. Robertson, W. Oetgen (2013)
The next steps in developing clinical practice guidelines for prevention.Journal of the American College of Cardiology, 62 15
-
(2002)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation, 106 25
-
N. Baykal (2009)
Health InformaticsAdvances in experimental medicine and biology, 553
-
N. Stone, Jennifer Robinson, A. Lichtenstein, C. Noel, B. Merz, D. Lloyd‐Jones, C. Blum, P. Mcbride, R. Eckel, F. Schwartz, A. Goldberg, Susan Shero, Rn, D. Gordon, Sidney Smith, D. Levy, K. Watson, P. Wilson, Karen Eddleman, N. Jarrett, K. Labresh, Lev Nevo, J. Wnek, Jeffrey Anderson, J. Halperin, N. Albert, J. Hochman, B. Bozkurt, R. Kovacs, R. Brindis, Macc Ohman, L. Curtis, S. Pressler, D. DeMets, F. Sellke, R. Guyton, W. Shen, G. Tomaselli, Stone Nj, Robinson J, Lichtenstein Ah, M. Bairey, Blum Cn, Eckel Cb, Goldberg Rh, Gordon Ac, Levy D, Lloyd-Jones Dm, P. Mcbride, Js Schwartz, Shero St, Smith Sc, W. Wilson (2014)
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation, 129 25 Suppl 2
-
C. Furberg, J. Wright, B. Davis, J. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. Haywood, F. Leenen (2002)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).JAMA, 288 23
-
T. Anderson, I. Meredith, A. Yeung, B. Frei, A. Selwyn, P. Ganz (1995)
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.The New England journal of medicine, 332 8
-
Tracy Wolff, Therese Miller, S. Ko (2009)
Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 150
-
J Perk, G Backer, H Gohlke, I Graham, Z Reiner, M Verschuren (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Eur Heart J, 33
-
C. Bang, P. Okin (2014)
Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic ReviewCurrent Cardiology Reports, 16
-
Y. Ikeda, K. Shimada, T. Teramoto, S. Uchiyama, T. Yamazaki, S. Oikawa, M. Sugawara, K. Ando, M. Murata, K. Yokoyama, N. Ishizuka (2014)
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.JAMA, 312 23
-
P. Sever, B. Dahlöf, N. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S. Kjeldsen, A. Kristinsson, G. Mcinnes, J. Mehlsen, M. Nieminen, E. O’Brien, J. Östergren, Ascot Investigators (2012)
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled TrialDrugs, 64
-
M. Santos, M. Fuset, M. Ruano, A. Moscardó, J. Vallés (2009)
Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.The American journal of cardiology, 104 12
-
AndrewJ. Coats (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 360
-
Scandinavian Group (1994)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 344
-
K. Jennewein, T. Durand, A. Gerybadze (2010)
When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer AspirinManagement international, 14
-
W. Taylor, N. Unwin (2009)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National -
J. Tobert (2003)
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitorsNature Reviews Drug Discovery, 2
-
A. Rabinstein (2006)
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenYearbook of Neurology and Neurosurgery, 2006
-
J. Gutierrez, G. Ramirez, T. Rundek, R. Sacco (2012)
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.Archives of internal medicine, 172 12
-
M. Pencina, A. Navar-Boggan, R. D'Agostino, K. Williams, Benjamin Neely, A. Sniderman, E. Peterson (2014)
Application of new cholesterol guidelines to a population-based sample.The New England journal of medicine, 370 15
-
E. Michos, K. Nasir, J. Braunstein, J. Rumberger, M. Budoff, W. Post, R. Blumenthal (2006)
Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women.Atherosclerosis, 184 1
-
R. Kruijsdijk, F. Visseren, P. Ridker, J. Dorresteijn, J. Buring, Y. Graaf, N. Cook (2014)
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy womenHeart, 101
-
A. Go, D. Mozaffarian, V. Roger, E. Benjamin, J. Berry, M. Blaha, S. Dai, E. Ford, C. Fox, Sheila Franco, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, Mark Huffman, S. Judd, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, R. Mackey, D. Magid, G. Marcus, A. Marelli, D. Matchar, Darren Mcguire, E. Mohler, C. Moy, M. Mussolino, R. Neumar, G. Nichol, D. Pandey, N. Paynter, M. Reeves, P. Sorlie, J. Stein, A. Towfighi, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2014)
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.Circulation, 129 3
-
T. Jacobson (2008)
Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.Mayo Clinic proceedings, 83 6
-
Aesha Drozdowski (2004)
Standards of medical care in diabetes.Diabetes care, 27 Suppl 1
-
D. Lloyd‐Jones, D. Goff, N. Stone (2014)
Statins, risk assessment, and the new American prevention guidelinesThe Lancet, 383
-
T. Meade, M. Epidemiology (1998)
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased riskThe Lancet, 351
-
G. Gaetano (2001)
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.Lancet, 357 9250
-
S. Yusuf (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. CommentaryThe Lancet, 360
-
J. Brugts, T. Yetgin, S. Hoeks, A. Gotto, J. Shepherd, R. Westendorp, A. Craen, R. Knopp, H. Nakamura, P. Ridker, R. Domburg, J. Deckers (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsThe BMJ, 338
- Publisher
- Springer Journals
- Copyright
- Copyright © 2015 by Springer International Publishing Switzerland
- Subject
- Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- DOI
- 10.1007/s40256-015-0111-x
- pmid
- 25812803
- Publisher site
- See Article on Publisher Site
Abstract
Cardiovascular disease continues to be the most common cause of mortality in women in the USA. As a result, greater emphasis has been placed on preventive measures. Studies examining the role of aspirin and HMG-CoA reductase inhibitors (statins) have shown important clinical differences in men versus women in the preventive realm. This has led to inconsistent recommendations by guideline committees and clinicians alike. This review presents a summary of the past and current guidelines. In addition, important clinical trials influencing current era practice are also discussed. Both strengths and limitations of these studies are described in detail, along with recommendations regarding future directions and the scope of aspirin and statin use for primary and secondary prevention of cardiovascular disease.
Journal
American Journal of Cardiovascular Drugs – Springer Journals
Published: Mar 27, 2015